Evaluation of the clinical efficacy and safety of fluticasone propionate/ formoterol fumarate combination (FFC) for the treatment of bronchial asthma-with and without use of an inhalation device
Not Applicable
Recruiting
- Conditions
- Bronchial Asthma
- Registration Number
- JPRN-UMIN000015602
- Lead Sponsor
- Kinki university Department of respiratory medicine and allergology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with any serious cardiac, hepatic, renal, hematological disorder, or any other serious complication 2) Patients who have coexisting malignant tumor or a history of malignant tumor 3) Patients who have history of smoking within the past 1 year 4) Patients who are pregnant, lactating, possibly pregnant, or those who desire to become pregnant during their participation in the study 5) Others deemed unsuitable by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FEV1
- Secondary Outcome Measures
Name Time Method ung function Score Asthma Control Questionnaire FeNO Impulse Oscillation System